45 related articles for article (PubMed ID: 11826739)
1. [SSRI and SNRI treatment in children and adolescents. Current views of the benefits and risks].
Holtkamp K; Herpertz-Dahlmann B
Nervenarzt; 2008 Nov; 79(11):1237-8, 1240, 1243-4, passim. PubMed ID: 18958442
[TBL] [Abstract][Full Text] [Related]
2. [The off-label-prescription of TNF-alpha blocking agents for spondyloarthropathies in the context of recent statement by a German federal court].
Sieper J
Z Rheumatol; 2002 Dec; 61(6):688-93. PubMed ID: 12491132
[TBL] [Abstract][Full Text] [Related]
3. Experimental therapies: Investigator-initiated cancer trials with INDs for approval in Japan.
Imamura CK; Takebe N; Nakamura S; Saya H; Ueno NT
Nat Rev Clin Oncol; 2010 Mar; 7(3):127-8. PubMed ID: 20190792
[No Abstract] [Full Text] [Related]
4. New FDA breakthrough-drug category--implications for patients.
Darrow JJ; Avorn J; Kesselheim AS
N Engl J Med; 2014 Mar; 370(13):1252-8. PubMed ID: 24670173
[No Abstract] [Full Text] [Related]
5. [Therapy with not yet approved drugs or for not yet approved indications].
Wollenhaupt J
Z Rheumatol; 2001 Dec; 60(6):450-2. PubMed ID: 11826739
[No Abstract] [Full Text] [Related]
6. [Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].
Manger B;
Z Rheumatol; 2002 Dec; 61(6):694-7. PubMed ID: 12491133
[No Abstract] [Full Text] [Related]
7. Notification vs approval.
Novack GD
Ocul Surf; 2007 Jul; 5(3):255-8. PubMed ID: 17660899
[No Abstract] [Full Text] [Related]
8. Investigational agents for rheumatoid arthritis.
Merkel PA; Letourneau EN; Polisson RP
Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
[TBL] [Abstract][Full Text] [Related]
9. Vitaxin applied molecular evolution.
Mikecz K
Curr Opin Investig Drugs; 2000 Oct; 1(2):199-203. PubMed ID: 11249574
[TBL] [Abstract][Full Text] [Related]
10. Biological therapies for rheumatoid arthritis: progress to date.
Malviya G; Salemi S; Laganà B; Diamanti AP; D'Amelio R; Signore A
BioDrugs; 2013 Aug; 27(4):329-45. PubMed ID: 23558378
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
